Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bill H Chang

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Blood Neoplasia|June 30, 2026
Ixazomib with chemotherapy for childhood relapsed acute lymphoblastic leukemia: a TACL consortium reportEric S Schafer, Holly L Pacenta, Yueh-Yun Chi, et al.
Cancer Research|October 23, 2012
Kinase pathway dependence in primary human leukemias determined by rapid inhibitor screeningJeffrey W Tyner, Wayne F Yang, Armand Bankhead, et al.
American Journal of Hematology|February 18, 2022
Decitabine and vorinostat with FLAG chemotherapy in pediatric relapsed/refractory AML: Report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortiumLauren Pommert, Eric S Schafer, Jemily Malvar, et al.
Cancer Discovery|March 9, 2013
TYK2-STAT1-BCL2 pathway dependence in T-cell acute lymphoblastic leukemiaTakaomi Sanda, Jeffrey W Tyner, Alejandro Gutierrez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2018
Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0622William B Slayton, Kirk R Schultz, John A Kairalla, et al.
Pediatric Blood & Cancer|February 12, 2025
Vincristine Sulfate Liposome Injection With Combination Chemotherapy for Children, Adolescents, and Young Adults With Relapsed Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium TrialNirali N Shah, Eric S Schafer, Yueh-Yun Chi, et al.
Blood|February 26, 2025
A CEBPB/IL-1β/TNF-α feedback loop drives drug resistance to venetoclax and MDM2 inhibitors in monocytic leukemiaBasil Allen, Daniel Bottomly, Thomas Köhnke, et al.
The Lancet. Haematology|February 15, 2026
Bortezomib and vorinostat in combination with mitoxantrone, dexamethasone, and pegasparaginase during induction and reinduction for infants with acute lymphoblastic leukaemia: a multicentre single-arm phase 1/2 studyTanja A Gruber, Sima Jeha, Rebecca J Deyell, et al.
Cancer Cell|March 12, 2015
Self-enforcing feedback activation between BCL6 and pre-B cell receptor signaling defines a distinct subtype of acute lymphoblastic leukemiaHuimin Geng, Christian Hurtz, Kyle B Lenz, et al.
Blood|January 27, 2017
Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemiaViktoras Frismantas, Maria Pamela Dobay, Anna Rinaldi, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Blood Neoplasia|June 30, 2026
Ixazomib with chemotherapy for childhood relapsed acute lymphoblastic leukemia: a TACL consortium reportEric S Schafer, Holly L Pacenta, Yueh-Yun Chi, et al.
Cancer Research|October 23, 2012
Kinase pathway dependence in primary human leukemias determined by rapid inhibitor screeningJeffrey W Tyner, Wayne F Yang, Armand Bankhead, et al.
American Journal of Hematology|February 18, 2022
Decitabine and vorinostat with FLAG chemotherapy in pediatric relapsed/refractory AML: Report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortiumLauren Pommert, Eric S Schafer, Jemily Malvar, et al.
Cancer Discovery|March 9, 2013
TYK2-STAT1-BCL2 pathway dependence in T-cell acute lymphoblastic leukemiaTakaomi Sanda, Jeffrey W Tyner, Alejandro Gutierrez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2018
Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0622William B Slayton, Kirk R Schultz, John A Kairalla, et al.
Pediatric Blood & Cancer|February 12, 2025
Vincristine Sulfate Liposome Injection With Combination Chemotherapy for Children, Adolescents, and Young Adults With Relapsed Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium TrialNirali N Shah, Eric S Schafer, Yueh-Yun Chi, et al.
Blood|February 26, 2025
A CEBPB/IL-1β/TNF-α feedback loop drives drug resistance to venetoclax and MDM2 inhibitors in monocytic leukemiaBasil Allen, Daniel Bottomly, Thomas Köhnke, et al.
The Lancet. Haematology|February 15, 2026
Bortezomib and vorinostat in combination with mitoxantrone, dexamethasone, and pegasparaginase during induction and reinduction for infants with acute lymphoblastic leukaemia: a multicentre single-arm phase 1/2 studyTanja A Gruber, Sima Jeha, Rebecca J Deyell, et al.
Cancer Cell|March 12, 2015
Self-enforcing feedback activation between BCL6 and pre-B cell receptor signaling defines a distinct subtype of acute lymphoblastic leukemiaHuimin Geng, Christian Hurtz, Kyle B Lenz, et al.
Blood|January 27, 2017
Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemiaViktoras Frismantas, Maria Pamela Dobay, Anna Rinaldi, et al.
Pageof 6